Literature DB >> 6245361

Oral retinoid treatment of human papillomavirus type 5-induced epidermodysplasia verruciformis.

M A Lutzner, C Blanchet-Bardon.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6245361     DOI: 10.1056/NEJM198005083021919

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

Review 1.  Immunopathology of papillomavirus-induced warts and skin cancers in immunodepressed and immunosuppressed patients.

Authors:  M A Lutzner
Journal:  Springer Semin Immunopathol       Date:  1982

2.  Comparative study of systemic interferon alfa-2a with oral isotretinoin and oral isotretinoin alone in the treatment of recurrent condylomata accuminata.

Authors:  E K Cardamakis; I G Kotoulas; D P Dimopoulos; E N Stathopoulos; J T Michopoulos; V A Tzingounis
Journal:  Arch Gynecol Obstet       Date:  1996       Impact factor: 2.344

3.  Treatment of bovine-papillomavirus-type-1 (BPV)-transformed mouse cells with aromatic retinoid and retinoic acid.

Authors:  A Gassenmaier; M Lammel; E Kleiner; H Pfister
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

4.  Epidermodysplasia verruciformis induced by a new human papillomavirus (HPV-8). Report of a case without immune dysfunction. Effect of treatment with an aromatic retinoid.

Authors:  A L Claudy; J L Touraine; D Mitanne
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

5.  A phase I trial of topically applied trans-retinoic acid in cervical dysplasia-clinical efficacy.

Authors:  S A Weiner; E A Surwit; V E Graham; F L Meyskens
Journal:  Invest New Drugs       Date:  1986       Impact factor: 3.850

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.